Dong-A Pharmaceutical동아제약
000640 · KOSPI · ₩000640 · 동아제약
₩87,600▼ ₩900 (1.02%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 32.0% | 31.9% | 30.6% | 6.8% | 3.7% | 7.0% |
| Operating margin | 7.1% | 6.8% | 6.2% | 6.8% | 3.7% | 7.0% |
| Net margin | 5.6% | 6.4% | 4.4% | 5.1% | 1.1% | 6.8% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +6.2% | +7.2% | +17.8% | +11.5% | +15.1% | — |
| Operating income growth | +9.8% | +19.1% | +6.8% | +103.1% | −38.5% | — |
| Net income growth | −6.3% | +56.7% | +0.1% | +420.0% | −81.5% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 7.3% | 8.3% | 5.6% | 5.8% | 1.1% | 6.2% |
| Return on assets | 4.0% | 4.5% | 2.9% | 3.0% | 0.5% | 3.6% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 82.9% | 80.6% | 90.8% | 90.5% | 73.4% | 71.7% |
| Net debt to equity | 29.4% | 36.5% | 47.8% | 45.5% | 40.5% | 39.0% |
| Current ratio | 81.7% | 74.8% | 63.9% | 65.8% | 59.8% | 76.7% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Dong-A Pharmaceutical / 동아제약 / 000640 / KRX:000640
Source: KRX statistical information